Growing community of inventors

Los Angeles, CA, United States of America

Tulay Polat

Average Co-Inventor Count = 6.39

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

Tulay PolatChunlin Tao (7 patents)Tulay PolatDavid G Ho (7 patents)Tulay PolatQinwei Wang (7 patents)Tulay PolatLaxman Nallan (7 patents)Tulay PolatPatrick Soon-Shiong (3 patents)Tulay PolatNeil P Desai (3 patents)Tulay PolatXiaowen Sun (2 patents)Tulay PolatPaul Weingarten (1 patent)Tulay PolatForrest Arp (1 patent)Tulay PolatLukasz Koroniak (1 patent)Tulay PolatForrest Arp (1 patent)Tulay PolatDavid Ho (0 patent)Tulay PolatTulay Polat (7 patents)Chunlin TaoChunlin Tao (32 patents)David G HoDavid G Ho (15 patents)Qinwei WangQinwei Wang (14 patents)Laxman NallanLaxman Nallan (8 patents)Patrick Soon-ShiongPatrick Soon-Shiong (339 patents)Neil P DesaiNeil P Desai (142 patents)Xiaowen SunXiaowen Sun (7 patents)Paul WeingartenPaul Weingarten (10 patents)Forrest ArpForrest Arp (3 patents)Lukasz KoroniakLukasz Koroniak (2 patents)Forrest ArpForrest Arp (1 patent)David HoDavid Ho (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Nantbioscience, Inc. (4 from 9 patents)

2. Nantbio, Inc. (3 from 52 patents)


7 patents:

1. 10766879 - Pyrimidine derivatives as kinase inhibitors and their therapeutical applications

2. 10245261 - Substituted indol-5-ol derivatives and their therapeutic applications

3. 10160749 - Substituted indol-5-ol derivatives and their therapeutical applications

4. 9458137 - Substituted indol-5-ol derivatives and their therapeutical applications

5. 9409903 - Benzyl substituted triazine derivatives and their therapeutical applications

6. 9078902 - Triazine derivatives and their therapeutical applications

7. 8877924 - Benzyl substituted triazine derivatives and their therapeutical applications

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…